Prevalence of Cardiovascular Disease in Patients With Potentially Curable Malignancies
Nicolò Matteo Luca Battisti(Royal Marsden NHS Foundation Trust), Alistair Ring(Brighton and Sussex Medical School), Clive Weston(National Audit Office), Michael Sweeting(University of Cambridge), Mark de Belder(Barts Health NHS Trust), David Adlam(University of Leicester), John Deanfield(Barts Health NHS Trust), Michael Peake(University of Huddersfield), Catherine Welch(University College London)
Cited by 54
Related Papers
Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults
|Journal of the American College of Cardiology|2018|832
Association analyses based on false discovery rate implicate new loci for coronary artery disease
|Nature Genetics|2017|792
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England
|The Lancet|2020|747
Mechanisms of tamoxifen resistance
|Endocrine Related Cancer|2004|652
The expanding role of primary care in cancer control
|The Lancet Oncology|2015|544